Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.

Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J.

Magn Reson Med. 2006 Jun;55(6):1257-64.

2.

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.

Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS.

NMR Biomed. 2006 Feb;19(1):30-40.

PMID:
16229059
3.

Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues.

Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J.

Magn Reson Med. 2003 Nov;50(5):944-54.

4.

Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM.

AJR Am J Roentgenol. 2007 Jan;188(1):91-8.

PMID:
17179350
5.

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.

Shukla-Dave A, Hricak H, Moskowitz C, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL.

Radiology. 2007 Nov;245(2):499-506. Epub 2007 Sep 21.

PMID:
17890357
6.

1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.

Wang XZ, Wang B, Gao ZQ, Liu JG, Liu ZQ, Niu QL, Sun ZK, Yuan YX.

Eur J Radiol. 2010 Feb;73(2):345-51. doi: 10.1016/j.ejrad.2008.10.035. Epub 2008 Dec 13.

PMID:
19070978
7.
8.

Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.

Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J.

Magn Reson Med. 2008 Jul;60(1):33-40. doi: 10.1002/mrm.21647.

9.

Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.

Canese R, Pisanu ME, Mezzanzanica D, Ricci A, Paris L, Bagnoli M, Valeri B, Spada M, Venditti M, Cesolini A, Rodomonte A, Giannini M, Canevari S, Podo F, Iorio E.

NMR Biomed. 2012 Apr;25(4):632-42. doi: 10.1002/nbm.1779. Epub 2011 Oct 24.

PMID:
22020805
10.

Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.

De Silva SS, Payne GS, Thomas V, Carter PG, Ind TE, deSouza NM.

NMR Biomed. 2009 Feb;22(2):191-8. doi: 10.1002/nbm.1302.

PMID:
18833545
11.

Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.

Scheenen TW, Heijmink SW, Roell SA, Hulsbergen-Van de Kaa CA, Knipscheer BC, Witjes JA, Barentsz JO, Heerschap A.

Radiology. 2007 Nov;245(2):507-16. Epub 2007 Sep 11.

PMID:
17848681
12.

1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas.

Righi V, Roda JM, Paz J, Mucci A, Tugnoli V, Rodriguez-Tarduchy G, Barrios L, Schenetti L, Cerdán S, García-Martín ML.

NMR Biomed. 2009 Jul;22(6):629-37. doi: 10.1002/nbm.1377.

PMID:
19322812
13.

Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.

Sitter B, Bathen TF, Singstad TE, Fjøsne HE, Lundgren S, Halgunset J, Gribbestad IS.

NMR Biomed. 2010 May;23(4):424-31. doi: 10.1002/nbm.1478. Epub 2010 Jan 25.

PMID:
20101607
15.

1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer.

Pearce JM, Mahoney MC, Lee JH, Chu WJ, Cecil KM, Strakowski SM, Komoroski RA.

MAGMA. 2013 Jun;26(3):337-43. doi: 10.1007/s10334-012-0349-0. Epub 2012 Oct 5.

PMID:
23053715
16.

Quantification and classification of high-resolution magic angle spinning data for brain tumor diagnosis.

Poullet JB, Martinez-Bisbal MC, Valverde D, Monleon D, Celda B, Arús C, Van Huffel S.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5407-10.

PMID:
18003231
17.

High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.

Valonen PK, Griffin JL, Lehtimäki KK, Liimatainen T, Nicholson JK, Gröhn OH, Kauppinen RA.

NMR Biomed. 2005 Jun;18(4):252-9.

PMID:
15884096
18.

Metabolite ratios in 1H MR spectroscopic imaging of the prostate.

Kobus T, Wright AJ, Weiland E, Heerschap A, Scheenen TW.

Magn Reson Med. 2015 Jan;73(1):1-12. doi: 10.1002/mrm.25122. Epub 2014 Jan 31. Review.

PMID:
24488656
19.

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.

Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA.

Radiology. 2008 Feb;246(2):480-8. doi: 10.1148/radiol.2462070368.

PMID:
18227542
20.

Semi-parametric time-domain quantification of HR-MAS data from prostate tissue.

Ratiney H, Albers MJ, Rabeson H, Kurhanewicz J.

NMR Biomed. 2010 Dec;23(10):1146-57. doi: 10.1002/nbm.1541. Epub 2010 Sep 15.

Supplemental Content

Support Center